FDA Inspection 1223662 — Integris BioServices LLC
The FDA completed an inspection of Integris BioServices LLC on October 20, 2023 in Olathe, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 20, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Olathe, KS (United States)
Additional Details
Bioanalytical BA/BE